Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Dr. Lal Path Labs Ltd. (NSE: LALPATHLAB), ISIN INE600L01024 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
LALPATHLAB last traded at ₹2010.00 (+2.03%), with a 52-week range of ₹1272.60 to ₹2079.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 52.93%, FIIs 18.73%, DIIs 21.57%, mutual funds 18.68%.
EquiSense Score (ECS): 69/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.